EconPapers    
Economics at your fingertips  
 

Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine

Till Bärnighausen (), David Bloom, David Canning (), A. Friedman, Orine Levine, Jennifer O'Brien, Lois Privor-Dumm and Damian Walker
Additional contact information
Till Bärnighausen: Harvard School of Public Health
A. Friedman: Harvard School of Public Health
Orine Levine: Harvard School of Public Health
Jennifer O'Brien: Harvard School of Public Health
Lois Privor-Dumm: Johns Hopkins School of Public Health
Damian Walker: Johns Hopkins School of Public Health

PGDA Working Papers from Program on the Global Demography of Aging

Abstract: Economic evaluations of health interventions, such as vaccinations, are important tools for informing health policy. Approaching the analysis from the appropriate perspective is critical to ensuring the validity of evaluation results for particular policy decisions. Using the example of benefit-cost analysis (BCA) of Haemophilus influenzae type b (Hib) vaccination, we demonstrate that past economic evaluations have mostly adopted narrow evaluation perspectives, focusing primarily on health gains, health care cost savings, and reductions in the time costs of caring, while ignoring other important benefits including outcome-related productivity gains (prevention of mental and physical disabilities), behavior-related productivity gains (economic growth due to fertility reductions as vaccination improves child survival), and community externalities (prevention of antibiotic resistance and herd immunity). We further show that the potential cost reductions that could be attained through changes in the delivery of the Hib vaccine have also usually been ignored in economic evaluations. Future economic evaluations of childhood vaccinations should take full account of benefits and costs, so that policy makers have sufficient information to make well-informed decisions on vaccination implementation.

Keywords: Economic evaluation; review; Haemophilus influenzae type b vaccine (search for similar items in EconPapers)
Date: 2010-04
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1) Track citations by RSS feed

Downloads: (external link)
http://www.hsph.harvard.edu/pgda/WorkingPapers/2010/PGDA_WP_57.pdf (application/pdf)
Our link check indicates that this URL is bad, the error code is: 404 Not Found (http://www.hsph.harvard.edu/pgda/WorkingPapers/2010/PGDA_WP_57.pdf [301 Moved Permanently]--> https://www.hsph.harvard.edu/pgda/WorkingPapers/2010/PGDA_WP_57.pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gdm:wpaper:5610

Access Statistics for this paper

More papers in PGDA Working Papers from Program on the Global Demography of Aging
Bibliographic data for series maintained by Cinzia Smothers (). This e-mail address is bad, please contact .

 
Page updated 2019-10-16
Handle: RePEc:gdm:wpaper:5610